Columbia Labs
This article was originally published in The Tan Sheet
Executive Summary
Licenses rights to Replens and Feminesse products in the U.K. to Unipath, a division of Unilever. The deal includes "up-front payments for the products" to Columbia Labs and an exclusive supply agreement on future sales, Columbia said. The company also will receive additional payments if further indications are cleared by British health authorities. In the U.K., Replens is sold to treat vaginal dryness and Feminesse is marketed for the prevention of vaginal odor